Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Women With Recurrent Ovarian Cancer: an Open-label, Single-arm Phase II Clinical Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Doxorubicin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 15 Oct 2014 Biomarkers information updated
- 19 Mar 2013 New trial record